You have 9 free searches left this month | for more free features.

Overall Status

Not yet recruiting (32)

Recruiting (17)

Enrolling by invitation (2)

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (42)

phase 1/phase 2 (3)

phase 3 (2)

n/a (1)

phase 1 (1)

Collaborator

Study Documents

Intervention Type

drug (50)

radiation (4)

procedure (3)

biological (1)

Funder Type

Other (44)

Industry (8)

Study Type

Interventional (49)

Observational (3)

envafolimab

Showing 51 - 52 of 52

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Leptomeningeal Metastasis, Immune Checkpoint Inhibitor, Endostatin Trial in Hebei (Camrelizumab or envafolimab)

Recruiting

Leptomeningeal Metastasis
+2 more

Camrelizumab or envafolimab

Hebei, China

The Second Hospital of Hebei Medical University

May 19, 2022

Potentially Resectable Hepatocellular Carcinoma Trial (FOLFOX-HAIC+Lenvatinib+Envolizumab)

Not yet recruiting

Potentially Resectable Hepatocellular Carcinoma

FOLFOX-HAIC+Lenvatinib+Envolizumab

(no location specified)

Nov 16, 2023